CAN-FITE BIOPHARMA LTD.

Transcripts Can-Fite BioPharma Ltd.

Equities

CANF

IL0010944739

Pharmaceuticals

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:52 2025-07-14 am EDT			5-day change	1st Jan Change
1.300 ^ILa	0.00%		0.00%	-31.58%

Jun. 16	Can-Fite to Present Phase IIa Pancreatic Cancer Study Progress During Partnering Meetings at the 2025 BIO International Convention in Boston	CI
May. 05	Can-Fite Says It Has Raised $175 Million To Date For Development Of Namodenoson And Piclidenoson	RE

Transcripts

Can-Fite BioPharma Ltd. - Special Call	Feb. 25
Can-Fite BioPharma Ltd. - Special Call	Nov. 23
Can-Fite BioPharma Ltd. - Special Call	24-10-29
Can-Fite BioPharma Ltd. - Special Call	24-08-10
Can-Fite BioPharma Ltd. - Special Call	24-08-08
Can-Fite BioPharma Ltd. - Special Call	24-06-06
Can-Fite BioPharma Ltd. - Special Call	24-05-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

Optimize my profits